Anti-TFR Antibody

Catalog #
101595
$325 *
Size: 50 µg
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

Recombinant human anti-TFR antibody designed towards human TFR (transferrin receptor). This anti-TFR antibody is a purified recombinant antibody. This antibody contains an Avi-Tag™ on the C-terminus of the Heavy Chain.

Synonyms
TR, TfR, TfR1, Trfr, Transferrin receptor protein 1, T9, p90, TFRC
Product Info
Storage and Usage
Citations
Species
Human
Isotype
IgG1
Clonality
Monoclonal
Host Species/Expression System
HEK293
Purity

≥90%

Format

Aqueous buffer solution.

Formulation

8 mM phosphate, pH 7.4, 110 mM NaCl, 2.2 mM KCl, and 20% glycerol

MW
Heavy Chain: 51 kDa + glycans; Light Chain: 24 kDa
Glycosylation
This antibody has a higher MW by SDS-PAGE due to glycosylation.
UniProt #
P02786
Background

TFR (transferrin receptor protein-1), also known as TfR1 or CD71, is a cell surface receptor that binds holo-transferrin (Tf) with high affinity, forming an iron-Tf-TfR complex that is endocytosed. TFR1 is crucial for cellular health, as iron acts as a co-factor for many enzymes involved in metabolism and ROS (reactive oxygen species) formation. Deregulated iron levels, and consequently ROS formation, correlate with multiple disease states including Parkinson’s Disease, Amyotrophic Lateral Sclerosis (ALS), Huntington’s Disease, Multiple Sclerosis (MS), and tumorigenesis. TFR1 is upregulated on the surface of tumor cells and endothelial cells in the brain, presenting TFR1 as a promising candidate for targeted therapy in leukemia, lymphoma and neurological diseases. Studies of TFR1 function and expression patterns will broaden our knowledge and support possible applications in therapy.